Blockade of TNF does not alter oxygen burst and phagocytosis of human neutrophils in patients with rheumatoid arthritis

This publication has 31 references indexed in Scilit:

• Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response
  Cytometry Part A, 2003
• Tuberculous tonsillitis in a patient receiving etanercept treatment
  Annals of the Rheumatic Diseases, 2003
• Priming effects of GM-CSF, IFN-γ and TNF-α on human neutrophil inflammatory cytokine production
  Melanoma Research, 2002
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis
  Arthritis & Rheumatism, 2000
• Killing ofMycobacterium aviumby Neutrophils and Monocytes from AIDS Patients Treated with Recombinant Granulocyte‐Macrophage Colony‐Stimulating Factor
  The Journal of Infectious Diseases, 1999
• Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.
  Journal of Clinical Investigation, 1991
• Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Qualitative and quantitative differences
  Biochemical and Biophysical Research Communications, 1990
• Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
  Arthritis & Rheumatism, 1988
• Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme.
  The Journal of Experimental Medicine, 1984